[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591732":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":22,"locations":28,"responsibleParty":57,"collaborators":10,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":78,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"CBB",null,"Hypofractionated breast radiotherapy following partial mastectomy in patients with early breast cancer or ductal breast carcinoma in situ",[13],"Radiation: Hypofractionated Radiation Therapy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"RADIATION","Hypofractionated Radiation Therapy","Hypofractionated breast radiotherapy (HFRT) with hybrid techniques combining field-in-field intensity-modulated RT (FIF-IMRT) to the whole breast with inverse-IMRT for concomitant boost",[9],[21],"Hypofractionated breast radiotherapy with concomitant boost",[23],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Yen-Ting Liu","CONTACT","88697255451","nickliucool@ntuh.gov.tw",[29,47],{"facility":5,"status":30,"city":31,"state":32,"zip":33,"country":32,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"NOT_YET_RECRUITING","Taipei","Taiwan","100","TW",{"type":36,"coordinates":37},"Point",[38,39],121.52639,25.05306,{"lat":39,"lon":38},[42,44],{"name":24,"role":25,"phone":43,"phoneExt":10,"email":27},"886972655451",{"name":45,"role":46,"phone":10,"phoneExt":10,"email":10},"Sung-Hsin Kuo","PRINCIPAL_INVESTIGATOR",{"facility":48,"status":49,"city":31,"state":10,"zip":50,"country":32,"countryCode":34,"cosmosGeoPoint":51,"geoPoint":53,"contacts":54},"National Taiwan University Hospital Yunlin Branch","RECRUITING","632",{"type":36,"coordinates":52},[38,39],{"lat":39,"lon":38},[55,56],{"name":24,"role":25,"phone":43,"phoneExt":10,"email":27},{"name":24,"role":46,"phone":10,"phoneExt":10,"email":10},{"type":58,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100591732","hypofractionated-radiotherapy-with-concomitant-tumor-bed-boost-for-breast-cancer-100591732",false,"NCT06984250","Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer","Hybrid Techniques Combining Hypofractionated Whole Breast Radiotherapy With Concomitant Tumor Bed Boost in Patients With Breast Cancer","HFCBB","Inclusion Criteria:\n\n* Female patients with histologically confirmed early-stage breast cancer (T1-2 and N0-1) or ductal carcinoma in situ (DCIS).\n* Patients undergoing breast-conserving surgery\n* Age ≥ 20 years\n* Karnofsky Performance Status (KPS) ≥70%\n* Life expectancy ≥ 5 years\n* Adequate renal and hepatic function\n\nExclusion Criteria:\n\n* Pregnant patients\n* Patients requiring re-irradiation of the thoracic region","FEMALE","20 Years","85 Years",{"count":71,"type":72},315,"ESTIMATED","OBSERVATIONAL","Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy",[76,77],"Early Breast Cancer","Ductal Breast Carcinoma In Situ",[79,80,81,82,83],"breast cancer","concomitant boost","tumor bed","Intensity-modulated radiation therapy","hypofractionated breast radiotherapy","2025-05-19",{"date":86,"type":87},"2025-05-22","ACTUAL",{"date":89,"type":87},"2025-02-06",{"date":91,"type":72},"2030-02-28",{"name":5,"class":6},2]